Farrerol Alleviates Hypoxic-Ischemic Encephalopathy by Inhibiting Ferroptosis in Neonatal Rats via the Nrf2 Pathway
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Farrerol Alleviates Hypoxic-Ischemic Encephalopathy by Inhibiting Ferroptosis in Neonatal Rats via the Nrf2 Pathway
Authors
Keywords
-
Journal
PHYSIOLOGICAL RESEARCH
Volume -, Issue -, Pages 511-520
Publisher
Institute of Physiology of the Czech Academy of Sciences
Online
2023-10-02
DOI
10.33549/physiolres.935040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BMS-470539 Attenuates Oxidative Stress and Neuronal Apoptosis via MC1R/cAMP/PKA/Nurr1 Signaling Pathway in a Neonatal Hypoxic-Ischemic Rat Model
- (2022) Shufeng Yu et al. Oxidative Medicine and Cellular Longevity
- Farrerol alleviates collagenase‐induced tendinopathy by inhibiting ferroptosis in rats
- (2022) Yongfu Wu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia
- (2022) Chen Fu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Ferroptosis is Involved in Hypoxic-ischemic Brain Damage in Neonatal Rats
- (2022) Wei Lin et al. NEUROSCIENCE
- Glycyrrhizin Attenuates Hypoxic-Ischemic Brain Damage by Inhibiting Ferroptosis and Neuroinflammation in Neonatal Rats via the HMGB1/GPX4 Pathway
- (2022) Kaiyi Zhu et al. Oxidative Medicine and Cellular Longevity
- Dihydroartemisinin attenuates hypoxic-ischemic brain damage in neonatal rats by inhibiting oxidative stress
- (2022) Qian Xiong et al. Molecular Brain
- Farrerol Alleviates Myocardial Ischemia/Reperfusion Injury by Targeting Macrophages and NLRP3
- (2022) Lin Zhou et al. Frontiers in Pharmacology
- SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/ SLC7A11 / GPX4 signaling
- (2022) Chong Zeng et al. CANCER SCIENCE
- Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
- (2022) Brent R. Stockwell CELL
- Ferroptosis: A Promising Therapeutic Target for Neonatal Hypoxic-Ischemic Brain Injury
- (2022) Eric S. Peeples et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activation of the P62-Keap1-NRF2 Pathway Protects against Ferroptosis in Radiation-Induced Lung Injury
- (2022) Xuan Li et al. Oxidative Medicine and Cellular Longevity
- Astragaloside IV regulates the ferroptosis signaling pathway via the Nrf2/SLC7A11/GPX4 axis to inhibit PM2.5-mediated lung injury in mice
- (2022) Xiaoming Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- An NADPH sensor that regulates cell ferroptosis
- (2022) Guixing Kuang et al. Journal of Translational Medicine
- The NOTCH-HES-1 axis is involved in promoting Th22 cell differentiation
- (2021) Chong Zeng et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Perinatal Hypoxic-Ischemic Damage: Review of the Current Treatment Possibilities
- (2021) A FRAJEWICKI et al. PHYSIOLOGICAL RESEARCH
- Farrerol Induces Cancer Cell Death via ERK Activation in SKOV3 Cells and Attenuates TNF-α-Mediated Lipolysis
- (2021) Jongbeom Chae et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of TLR4 prevents hippocampal hypoxic-ischemic injury by regulating ferroptosis in neonatal rats
- (2021) Kaiyi Zhu et al. EXPERIMENTAL NEUROLOGY
- The pharmacological properties and corresponding mechanisms of farrerol: a comprehensive review
- (2021) Xiaojiang Qin et al. PHARMACEUTICAL BIOLOGY
- Scutellarin ameliorates neonatal hypoxic-ischemic encephalopathy associated with GAP43-dependent signaling pathway
- (2021) Rui-Ze Niu et al. Chinese Medicine
- Farrerol Ameliorated Cisplatin-Induced Chronic Kidney Disease Through Mitophagy Induction via Nrf2/PINK1 Pathway
- (2021) Ning Ma et al. Frontiers in Pharmacology
- Pathophysiology of hypoxic–ischemic encephalopathy: a review of the past and a view on the future
- (2020) P. Greco et al. ACTA NEUROLOGICA BELGICA
- Corrigendum to ‘Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways’. [Int. Immunopharmacol. 75 (2019) 105739]
- (2020) Yuhang Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Farrerol Directly Targets GSK-3β to Activate Nrf2-ARE Pathway and Protect EA.hy926 Cells against Oxidative Stress-Induced Injuries
- (2020) Chaoqun Yan et al. Oxidative Medicine and Cellular Longevity
- Asiaticoside attenuates neonatal hypoxic–ischemic brain damage through inhibiting TLR4/NF-κB/STAT3 pathway
- (2020) Yu Zhou et al. Annals of Translational Medicine
- Melatonin Suppresses Ferroptosis Induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis
- (2020) Hongdong Ma et al. Oxidative Medicine and Cellular Longevity
- Farrerol attenuates MPP+ -induced inflammatory response by TLR4 signaling in a microglia cell line
- (2019) Bei Cui et al. PHYTOTHERAPY RESEARCH
- Protective role of citric acid against oxidative stress induced by heavy metals in Caenorhabditis elegans
- (2019) Shaojuan Song et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- New Insights into the Nrf-2/HO-1 Signaling Axis and Its Application in Pediatric Respiratory Diseases
- (2019) Xueyan Zhang et al. Oxidative Medicine and Cellular Longevity
- Farrerol Attenuates Cisplatin-Induced Nephrotoxicity by Inhibiting the Reactive Oxygen Species-Mediated Oxidation, Inflammation, and Apoptotic Signaling Pathways
- (2019) Ning Ma et al. Frontiers in Physiology
- Farrerol attenuates β-amyloid-induced oxidative stress and inflammation through Nrf2/Keap1 pathway in a microglia cell line
- (2018) Bei Cui et al. BIOMEDICINE & PHARMACOTHERAPY
- Current knowledge on oxidative stress in hepatic ischemia/reperfusion
- (2013) M. Elias-Miró et al. FREE RADICAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started